Study finds tall and/or obese men at higher risk of aggressive prostate cancer

Dr. David Samadi provides his expert commentary on a recent large European prospective study finding evidence that men with greater height and adiposity (high BMI and waist circumference) have an elevated risk of high-grade prostate cancer and prostate cancer death. 

Read More

New Hope for Advanced Prostate Cancer

New Hope for Advanced Prostate Cancer

A study has proclaimed that the new drug, abiraterone, lowers patients' risk of death by nearly 40 percent when added to standard androgen deprivation therapy (ADT). It also appears to more than double the average time it takes for prostate cancer to progress.

Read More